|
Mylan Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Metabolic Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
500 |
Global |
$2,995.00 |
|
|
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2017: Deal trends, players and financials |
Sep 1 2017 |
457 |
Global |
$2,995.00 |
|
|
Global Esophageal Reflux Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Tropical Disease Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
The Medicines Company Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Endo Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Cervical Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Hospira Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Transdermal Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
160 |
Global |
$1,995.00 |
|
|
Global Contraception Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Migraine Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Blood Substitutes Partnering 2010-2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Actavis Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Rheumatoid Arthritis Partnering 2010 to 2017 |
Sep 1 2017 |
200 |
Global |
$1,495.00 |
|
|
AstraZeneca Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Dementia Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Monsanto Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Bacterial Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
800 |
Global |
$2,995.00 |
|
|
Global In Vitro Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
660 |
Global |
$2,995.00 |
|
|
Global Gastrointestinal Symptoms Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Parasitic Disease Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Targacept Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Eli Lilly Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Brain Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Targeted Drug Delivery Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
170 |
Global |
$1,995.00 |
|
|
Global Sexual Dysfunction Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
